Major PSC trial now recruiting
BUTEO, a single arm, two-stage, multi-centre, phase II clinical trial is now recruiting participants. The trial investigates the safety and activity of the use of BTT1023, a human monoclonal antibody …
New Chief Investigator and study team for UK-PSC
UK PSC has a new Chief Investigator. Dr Gideon Hirschfield successfully bid for the NIHR Rare Disease funding and is now leading the study. He is based at the NIHR …